Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | Dec-14 | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 1,826 | 2,438 | 3,188 | 2,096 | 2,679 | 1,869 | 931 | 880 | 1,158 | 965 | | 510 |
% Growth | NA | 33.5% | 30.8% | -34.3% | 27.8% | -30.2% | -50.2% | -5.5% | 31.6% | -16.7% | | |
| | | | | | | | | | | | |
Cost of Revenue | (1,229) | (1,817) | (2,167) | (775) | (1,205) | (918) | (516) | (385) | (531) | (526) | | (293) |
Gross Profit | 597 | 620 | 1,021 | 1,322 | 1,475 | 951 | 416 | 495 | 627 | 439 | | 217 |
% Revenue | 32.7% | 25.5% | 32.0% | 63.0% | 55.0% | 50.9% | 44.6% | 56.2% | 54.1% | 45.5% | | 42.6% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | (4) | (6) | (49) | (46) | (108) | (163) | | (167) |
Selling and Marketing | (65) | (48) | (66) | (35) | (31) | (37) | (17) | (19) | (13) | (27) | | (34) |
General and Admin | (59) | (65) | (71) | (86) | (95) | (100) | (110) | (146) | (166) | (203) | | (192) |
Other Inc / (Exp) | (153) | (147) | (101) | (179) | (190) | (122) | 29 | (19) | 3 | (25) | | (47) |
Total Operating Exp | (276) | (261) | (238) | (300) | (320) | (266) | (146) | (229) | (284) | (418) | | (440) |
| | | | | | | | | | | | |
Operating Income | 321 | 359 | 783 | 1,022 | 1,154 | 685 | 270 | 265 | 343 | 21 | | (223) |
% Revenue | 17.6% | 14.7% | 24.6% | 48.7% | 43.1% | 36.7% | 28.9% | 30.1% | 29.6% | 2.2% | | -43.8% |
| | | | | | | | | | | | |
Interest Expense | 297 | (6) | 185 | 1,208 | 151 | 95 | 147 | 232 | 171 | 148 | | 52 |
Pre-tax Income | 618 | 353 | 968 | 2,230 | 1,305 | 781 | 417 | 497 | 514 | 169 | | (171) |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (135) | (89) | (245) | (531) | (333) | (207) | (122) | (120) | (127) | (85) | | 36 |
Net Income to Company | 483 | 264 | 723 | 1,699 | 973 | 574 | 295 | 377 | 387 | 84 | | (135) |
% Margin | 26.5% | 10.8% | 22.7% | 81.0% | 36.3% | 30.7% | 31.7% | 42.8% | 33.4% | 8.7% | | -26.4% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (83) | (52) | (4) | 0 | (0) | (1) | 20 | (0) | 37 | 67 | | 91 |
Net Income to Stockholders | 400 | 211 | 718 | 1,699 | 972 | 573 | 315 | 377 | 424 | 151 | | (44) |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 400 | 211 | 718 | 1,699 | 972 | 573 | 315 | 377 | 424 | 151 | | (44) |
% Margin | 21.9% | 8.7% | 22.5% | 81.0% | 36.3% | 30.6% | 33.8% | 42.8% | 36.6% | 15.7% | | -8.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.41 | 0.22 | 0.74 | 1.76 | 1.01 | 0.62 | 0.35 | 0.41 | 0.46 | 0.16 | | (0.05) |
Diluted EPS (Continuing Ops) | 0.41 | 0.22 | 0.74 | 1.76 | 1.01 | 0.62 | 0.35 | 0.41 | 0.46 | 0.16 | | (0.05) |
| | | | | | | | | | | | |
WA Basic Shares Out. | 967.38 | 967.39 | 967.31 | 967.38 | 964.78 | 918.08 | 910.70 | 910.56 | 930.53 | 930.72 | | 910.33 |
WA Diluted Shares Out. | 967.38 | 967.39 | 967.31 | 967.38 | 964.78 | 918.08 | 910.70 | 910.56 | 930.53 | 930.72 | | 910.33 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 618 | 353 | 968 | 2,230 | 1,305 | 781 | 417 | 497 | 514 | 169 | | (171) |
Addback: Net Interest Expense | (297) | 6 | (185) | (1,208) | (151) | (95) | (147) | (232) | (171) | (148) | | (52) |
Addback: Other Non Operating Expenses, Total | (22) | (22) | (52) | 1 | 1 | 3 | 3 | (2) | (3) | 3 | | 8 |
Addback: Depreciation & Amortization | 2 | 2 | 2 | 6 | 12 | 22 | 22 | 25 | 29 | 30 | | 31 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 59 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 2 | (0) | (61) | (11) | (28) | (71) | (29) | | 25 |
Addback: Gain (Loss) On Sale Of Assets | 0 | (0) | (0) | 0 | 0 | (0) | 0 | (17) | (0) | (0) | | (0) |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 13 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | (2) | (1) | (7) | (49) | (12) | (9) | (11) | (3) | | (17) |
Adjusted EBITDA | 301 | 339 | 732 | 1,030 | 1,160 | 660 | 285 | 247 | 286 | 22 | | (176) |
% Margin | 16.5% | 13.9% | 22.9% | 49.1% | 43.3% | 35.3% | 30.6% | 28.1% | 24.7% | 2.2% | | -34.6% |
| | | | | | | | | | | | |
Adjusted EBIT | 299 | 337 | 729 | 1,024 | 1,148 | 637 | 263 | 222 | 258 | (9) | | (208) |
% Margin | 16.4% | 13.8% | 22.9% | 48.8% | 42.9% | 34.1% | 28.2% | 25.2% | 22.3% | -0.9% | | -40.7% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 483 | 264 | 723 | 1,699 | 973 | 574 | 295 | 377 | 387 | 84 | | (135) |
Addback: Unusual Items | 0 | (0) | (2) | 2 | (7) | (51) | (9) | (41) | (82) | (33) | | 8 |
Less: Tax Benefit of Unusual Items (26%) | (0) | 0 | 0 | (0) | 2 | 13 | 2 | 11 | 21 | 9 | | (2) |
Adjusted Net Income | 483 | 264 | 721 | 1,700 | 968 | 536 | 288 | 347 | 326 | 60 | | (129) |
% Margin | 26.5% | 10.8% | 22.6% | 81.1% | 36.1% | 28.7% | 30.9% | 39.4% | 28.1% | 6.2% | | -25.3% |